EP08.01-106. PD-1/PD-L1 Inhibitors Increase Myocardial Infarction in Osimertinib-Treated Patients with Non-Small Cell Lung Cancer
Back to course
Pdf Summary
Asset Subtitle
Lucheng Zhu
Meta Tag
Speaker Lucheng Zhu
Topic Metastatic Non-small Cell Lung Cancer - Immunotherapy
Keywords
PD-1/PD-L1 inhibitors
cardiac disorders
osimertinib
non-small cell lung cancer
NSCLC
EGFR-TKI
myocardial infarction
incidence
adverse event
confirmation
Powered By